Human Synuclein-gamma Control/blocking peptide # 2
General Information
The synuclein exists in 3 isoform -syn (chrm 4q21), a 140aa protein, implicated in pathogenesis of PD and related neurodegenerative disorders, it is mainly expressed in brain specifically in neuronal cell bodies and synapses. The 134 aa -syn (chrm 5q35)
SugApplications
Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization.
SpeciesReactivity
Human
Form
Antigen/blocking Peptide
Antigen
17aa peptide of Human Gamma SYN; Designated (SYN15-P or control peptide) conjugated to KLH; epitope location ~ C-terminus
SpCrossreactivity
The human SYN15-P peptide sequence is specific for human -synuclein. No significant sequence homology is seen with either rat/mouse -synuclein or synuclein-alpha or beta) or other proteins. We recommend the use of another antibody for rat -synuclein (SYN14-S) that is made using the rat sequence. Antibody cross reactivity in various species is not studies
For research use only, not for diagnostic or therapeutic use.
| Alpha Diagnostic International, Inc. | |
|---|---|
| Product Category | Biological Materials |
| Product Number | SYN15-P |
| Product Name | Human Synuclein-gamma Control/blocking peptide # 2 |